Sidebar
European nobles were famous for their inbreeding. Can you guess the conditions of Charles II of Spain (1661-1700)?
The Betrothal of the Virgin (‘Sposalizio’) by the famous painter Raphael is a classic piece of Renaissance art work. Within ...
We highlight a figure from patient advocate, Monty Goddard's article, A Two Headed Monster – State Attorneys General and the ...
We list the acquisition price of drugs that are covered under the Medicaid Drug Rebate Program - effectively, how much ...
As of October 27th, 2022, the highest hospitalization rates per 100,000 population were among adults aged ≥ 65 years (3.0) ...
Antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and ...
The percent increase in Producer Price Index of Health care services continues to rise at an increasing rate. This shows ...
Currently, the dominant variant nationwide is BA.5. "The original omicron variant is gone now, currently subvariants of omicron are circulating, including ...
Despite the >16% increase in US Covid hospitalizations (1,300 more added yesterday) over the past 10 days, a 17.5% test ...
Outpatient Visits for COVID-19 and Associated Antibiotic Prescriptions Among Medicare Beneficiaries Aged 65 Years or Older, by Setting, US, April ...
The street price of prescription drugs as well as illicit drugs is captured through a publicly-accessible website www.StreetRx.com. The site ...
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy